Halozyme Therapeutics, Inc.

HANCOCK WHITNEY CORP HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

242,465

Value ($000)

16,318

Weight

0.3%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	16,318	0.3%	242,465	12/31/2025
2025 Q3	11/17/2025	18,058	0.3%	246,221	9/30/2025
2025 Q2	8/14/2025	12,271	0.2%	235,895	6/30/2025
2025 Q1	5/15/2025	13,006	0.4%	203,818	3/31/2025
2024 Q4	2/14/2025	5,776	0.2%	120,811	12/31/2024
2024 Q3	11/13/2024	961	0.0%	16,796	9/30/2024
2024 Q2	8/13/2024	875	0.0%	16,716	6/30/2024
2024 Q1	5/16/2024	221	0.0%	5,430	3/31/2024
2023 Q4	2/14/2024	217	0.0%	5,869	12/31/2023
2023 Q3	11/13/2023	225	0.0%	5,877	9/30/2023
2023 Q2	11/13/2023	219	0.0%	6,084	6/30/2023
2023 Q1	11/13/2023	322	0.0%	8,429	3/31/2023
2022 Q4	11/13/2023	545	0.0%	9,577	12/31/2022
2022 Q3	10/26/2022	379	0.0%	9,597	9/30/2022
2022 Q2	8/8/2022	405	0.0%	9,211	6/30/2022
2022 Q1	5/12/2022	394	0.0%	9,881	3/31/2022
2021 Q4	1/25/2022	392	0.0%	9,753	12/31/2021
2021 Q3	11/4/2021	399	0.0%	9,820	9/30/2021
2021 Q2	8/9/2021	460	0.0%	10,120	6/30/2021
2021 Q1	5/14/2021	1,030	0.0%	24,698	3/31/2021
2020 Q4	2/9/2021	1,072	0.0%	25,092	12/31/2020
2020 Q3	11/5/2020	659	0.0%	25,060	9/30/2020
2020 Q2	7/30/2020	673	0.0%	25,098	6/30/2020
2020 Q1	5/8/2020	617	0.0%	34,274	3/31/2020
2019 Q4	2/6/2020	437	0.0%	24,627	12/31/2019